[1] Gruskin E, Doll BA, Futrell FW, et al. Demineralized bone matrix in bone repair: history and use. Adv Drug Deliv Rev. 2012;64(12):1063-1077.[2] Bohner M. Resorbable biomaterials as bone graft substitutes. Materials Today, 2010;13(1-2):24-30.[3] Hubbell JA. Biomaterials in tissue engineering. Biotechnology (N Y). 1995;13(6):565-576.[4] Geethaa M, Singh AK, Asokamani R, et al. Ti based biomaterials, the ultimate choice for orthopaedic implants – A review. Progress in Materials Science. 2009;54(3):397-425.[5] Kanczler JM, Ginty PJ, White L, et al. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials. 2010;31(6):1242-1250.[6] An G, Zhang WB, Ma DK, et al. Influence of VEGF/BMP-2 on the proliferation and osteogenetic differentiation of rat bone mesenchymal stem cells on PLGA/gelatin composite scaffold. Eur Rev Med Pharmacol Sci. 2017;21(10):2316-2328.[7] Deckers MM, van Bezooijen RL, van der Horst G, et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology. 2002;143(4):1545-1453.[8] Seong JM, Kim BC, Park JH, et al. Stem cells in bone tissue engineering. Biomed Mater. 2010;5(6):062001.[9] Yoshimoto H, Shin YM, Terai H, et al. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials. 2003;24(12):2077-2082.[10] Webster TJ, Waid MC, Mckenzie JL,et al. Nano-biotechnology: carbon nanofibres as improved neural and orthopaedic implants. Nanotechnology. 2004; 15(1): 48-54.[11] Woo KM, Chen VJ, Ma PX. Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. J Biomed Mater Res A. 2003;67(2):531-537.[12] Binulal NS, Deepthy M, Selvamurugan N, et al. Role of nanofibrous poly(caprolactone) scaffolds in human mesenchymal stem cell attachment and spreading for in vitro bone tissue engineering--response to osteogenic regulators. Tissue Eng Part A. 2010;16(2):393-404.[13] Wang J, Ma H, Jin X, et al. The effect of scaffold architecture on odontogenic differentiation of human dental pulp stem cells. Biomaterials. 2011;32(31):7822-7830.[14] Bianco P, Robey PG. Stem cells in tissue engineering. Nature. 2001;414(6859):118-121.[15] Cui F, Wang X, Liu X, et al. VEGF and BMP-6 enhance bone formation mediated by cloned mouse osteoprogenitor cells. Growth Factors. 2010;28(5):306-317.[16] Kanczler JM, Ginty PJ, White L, et al. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials. 2010;31(6):1242-1250.[17] Bauters C, Asahara T, Zheng LP, et al. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg. 1995;21(2): 314-324.[18] Peng H, Wright V, Usas A, et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest. 2002;110(6): 751-759.[19] Li G, Corsi-Payne K, Zheng B, et al. The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation.Tissue Eng Part A. 2009;15(8): 2123-2133.[20] Liu TM, Lee EH. Transcriptional regulatory cascades in Runx2-dependent bone development. Tissue Eng Part B Rev. 2013;19(3):254-263.[21] Liu W, Toyosawa S, Furuichi T, et al. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol. 2001;155(1): 157-166.[22] Neve A, Corrado A, Cantatore FP. Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol. 2013;228(6):1149-1153.[23] Peng H, Wright V, Usas A, et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest. 2002;110(6): 751-759.[24] Li G, Corsi-Payne K, Zheng B, et al. The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation. Tissue Eng Part A. 2009;15(8): 2123-2133. |